A comparative study of three kidney biomarker tests in autosomal-dominant polycystic kidney disease

Kidney International

Volumn 68, Issue 3, 2005, Pages 948-954

  Casal, J Antonio ^b   Hermida, Jesús ^b   Lens, Xosé M ^b   Tutor, J Carlos ^a  

^a Instituto de Salud Carlos III   (Spain)

^b NONE

Author keywords

N acetylhexosaminidase isoenzymes; Albuminuria; Autosomal dominant polycystic kidney disease; Cystatin C; Glutathione peroxidase; Ultrasound score

Indexed keywords

ALBUMIN; BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; GLUTATHIONE PEROXIDASE; ISOENZYME; UREA;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BETA-N-ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKERS; CREATINE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERTENSION, RENAL; ISOENZYMES; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; UREA;

EID: 32644459917     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00488.x     Document Type: Article

References (47)

1. GABOW PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329:332-342, 1993
2. PEI Y: Molecular genetics of autosomal dominant polycystic kidney disease. Clin Invest Med 26: 252-358, 2003
3. RIZK D, CHAPMAN AB: Cystic and inherited kidney diseases. Am J Kidney Dis 42:1305-1317, 2003
4. COWLEY DB: Recent advances in understanding the pathogenesis of polycystic kidney disease: Therapeutic implications. Drugs 64:1285-1294, 2004
5. SCARPIONI L, HEER EE: Fisipatología Protéica en las Neuropatías, Buenos Aires, Editorial Médica Panamericana, 1977, pp 76-87
6. CHAPMAN AB, JOHNSON AM, GABOW PA, SCHRIER RW: Overt proteinuria and microalbuminuria in autosomal polycystic kidney disease. J Am Soc Nephrol 5:1349-1354, 1994
7. SHARP C, JOHNSON A, GABOW P: Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 9:1908-1914, 1998
8. VAN DIJK MA, PETERS DJ, BREUNING MH, CHANG PC: The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 10:1916-1920, 1999
9. MARTINEZ-VEA A, GUTIERREZ C, BARDAJI A, et al: Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease. Scand J Urol Nephrol 32:356-359, 1998
10. SARASUA SM, MUELLER P, KATHMAN S, et al: Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study. Ren Fail 25:797-817, 2003
11. BOSOMWORTH MP, APARICIO SR, HAY AWM: Urine N-acetyl-β-D- glucosaminidase - A marker of tubular damage?. Nephrol Dial Transpl 14:620-666, 1999
12. SWEDENBORG P, HULTBERG B, THYSELL H: Urinary β-hexosaminidase excretion in polycystic kidney disease. Acta Med Scand 210:471-473, 1981
13. CARONE FA, OZONO S, SAMMA SS, et al: Renal functional changes in experimental cystic disease are tubular in origin. Kidney Int 33:8-13, 1988
14. WHITIN JC, THAM DM, BHAMRE S, et al: Plasma glutathione peroxidase and its relation ship to renal proximal tubule function. Molec Genet Metab 65:238-445, 1998
15. QUIAN Q, HARRIS PL, TORRES VE: Treatment prospects for autosomal-dominant polycystic kidney disease. Kidney Int 59:2005-2022, 2001
16. ITOH Y, NUMATA Y, MORITA A, et al: Varied value of urinary N-acetyl-β-D-glucosaminidase isoenzyme B in males of reproductive age. Kidney Int 46 (Suppl 47):S38-S42, 1994
17. PEREZ LF, TUTOR JC: Assay of β-N-acetyl-hexosaminidase isoenzymes in urine by means of determination of their activation energy without removing endogenous low-molecular-mass components. Clin Chim Acta 277:39-49, 1998
18. PEREZ LF, TUTOR JC: Assay of β-N-acetyl-hexosaminidase isoenzymes in different biological specimens by means of determination of their activation energies. Clin Chem 44:226-231, 1998
19. AMERICAN DIABETES ASSOCIATION (ADA): Diabetic nephropathy. Diabetes Care 20 (Suppl 1):S24-S27, 1997
20. LARSSON A, MALM J, GRUBB A, HANSSON LO: Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 64:25-30, 2004
21. COLL E, BOTEY A, ALVAREZ L, et al: Serum cystatin C as a new marker for non invasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36:29-34, 2000
22. LAMB EJ, O'RIORDAN SE, DELANEY MP: Kidney function in older people: Pathology, assessment and management. Clin Chim Acta 334:25-40, 2003
23. NATIONAL KIDNEY FOUNDATION: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Clasification and Stratification. Am J Kidney Dis 39 (Suppl 1):S76-S110, 2002
24. AVISSAR N, ORNT DB, YAGIL Y, et al: Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 266:C367-C315, 1994
25. SCHIAVON R, GUIDI GC, BIASIOLI S, et al: Plasma glutathione peroxidase activity as an index of renal function. Eur J Clin Chem Clim Biochem 32:759-765, 1994
26. YOSHIMURA S, SUEMIZU H, NOMOTO Y, et al: Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 73:207-211, 1996
27. ROXBOROUGH HE, MERCER C, MCMASTER D, et al: Plasma glutathione peroxidase activity is reduced in haemodialysis patients. Nephron 81:278-283, 1999
28. CZUCKEJKO J, ZACHARA BA, STAUBACH-TOPCZEWSKA E, et al: Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochim Pol 50:1147-1154, 2003
29. ZACHARA BA, SALAK A, KOTERSKA D, et al: Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 17:291-299, 2004
30. PÉREZ-BLANCO FJ, RUÍZ-MARTIN A, MORENO-TERRIBAS J: Urinary activity of N-acetyl-β-glucosaminidase (NAG) in arterial hypertensión. Clin Nephrol 45:65-66, 1996
31. TYLICKI L, MANITIUS J, LYSIAK-SZYDLOWSKA W, RUTKOWSKI B: Tubular injury: The first symptom of hypertensive kidney involvement? Med Sci Monit 9:CR135-CR141, 2003
32. LAPSLEY M, SANSOM PA, MARLOW CT, et al: β2-glycoprotein (apolipoprotein H) excretion in chronic renal tubular disorders: A comparison with other protein markers of tubular malfunction. J Clin Pathol 44:812-816, 1991
33. COSTIGAN MG, RUSTOM R, BONE JM, SHENKIN A: Origin and significance of urinary N-acetyl-β-D-glucosaminidase (NAG) in renal patients with proteinuria. Clin Chim Acta 255:133-144, 1996
34. HERMIDA J, CASAL JA, TUTOR JC: Effect of partial proteolysis on the activation anergy of β-N-acetylhexosaminidase precursor and mature forms. Clin Chem Lab Med 41:302-305, 2003
35. BOURBOUZE R, BAUMANN FC, BONVALET JP, FARMAN N: Distribution of N-acetyl-β-D-glucosaminidase isoenzymes along the rabit nephron. Kidney Int 25:636-642, 1984
36. BOURBOUZE R, BERNARD M, BAUMAN FC, et al: Localisation subcellulaire des isoenzymes de la N-acetyl-β-D-glucosaminidase du cortex rénal de lapin. Cell Molec Biol 30:67-74, 1984
37. BERNARD A, LAUWERIS R: Cadmium, NAG activity, and β2-microglobulin in the urine of cadmiun pigment workers. Br J Ind Med 46:679-680, 1989
38. HUTCHINSON T, DWIVEDI K, RASTOGI A, et al: N-Acetyl β-D- glucosaminidase is not attached to human sperm membranes through the glycosylphosphatidyl inositol (GPI)-anchor. Asian J Androl 4:27-33, 2002
39. HULTBERG B: Urinary excretion of β-hexosaminidase in different forms of proteinurie. Clin Chim Acta 108:195-199, 1980
40. RING E, ZOBEL G, ERWA W, HAIM-KUTTNIG M: Urinary excretion of N-acetyl-β-D-glucosaminidase in proteinuric states. Child Nephrol Urol 12:15-18, 1992
41. HULTBERG B, RAUNSKOV U: The excretion of N-acetyl-β-glucosaminidase in glomerulonephritis. Clin Nephrol 15:33-38, 1981
42. IGLESIAS J, LEVINE JS: Albuminuria and renal injury-beware of protein bearing gifts. Nephrol Dial Transpl 16:215-218, 2001
43. DAHAM M, VAN KOOTEN C: Is the proximal tubule a proinflammatory cell? Nephrol Dial Transpl 15 (Suppl 6):41-43, 2000
44. WONG H, VIVIAN L, WEILLER G, FILLER G: Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 43:624-638, 2004
45. FICK-BROSNAHAN GM, BELZ MM, MCFANN KK, et al: Relationship between renal growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. Am J Kidney Dis 39:1127-1131, 2002
46. SISE C, KUSAKA M, WETZEL LH, et al: Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int 58:2492-2501, 2000
47. YOSHIDA K: Demonstration of some properties of N-acetyl-β-D- hexosaminidase (Hex) C isoenzyme in human renal tissues: relative increase of Hex C activity in renal cell carcinoma. Clin Chim Acta 226:55-65, 1994